Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.66
-0.18 (-1.14%)
At close: May 29, 2025, 4:00 PM
15.64
-0.02 (-0.13%)
After-hours: May 29, 2025, 6:19 PM EDT

Mineralys Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,021613354---
Market Cap Growth
60.46%73.31%----
Enterprise Value
678349100---
Last Close Price
15.6612.318.60---
PB Ratio
2.973.201.47---
P/TBV Ratio
2.993.201.47---
Debt / Equity Ratio
------1.25
Quick Ratio
25.6313.5322.5713.652.100.28
Current Ratio
26.4814.0223.7713.982.200.29
Return on Equity (ROE)
-56.31%-82.24%-41.38%-53.00%-1568.96%-
Return on Assets (ROA)
-35.87%-52.56%-28.91%-31.34%-185.60%-
Return on Capital (ROIC)
-37.61%-55.62%-30.45%-34.99%-335.62%-
Earnings Yield
-18.47%-29.02%-20.34%---
FCF Yield
-18.88%-27.16%-22.96%---
Buyback Yield / Dilution
-22.76%-34.13%-600.33%-3.67%-7.64%-
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q